- Pharmazeutisches Institut
- protease inhibition
- PROTACs
- activity-based probes
Breidenbach J, Lemke C, Pillaiyar T, Schäkel L, Al Hamwi G, Diett M, Gedschold R, Geiger N, Lopez V, Mirza S, Namasivayam V, Schiedel AC, Sylvester K, Thimm D, Vielmuth C, Vu LP, Zyulina M, Bodem J, Gütschow M*, Müller CE* (2021) Targeting the main protease of SARS-CoV-2: From the establishment of high throughput screening to the design of tailored inhibitors. Angew Chem Int Ed 60:10423-10429.
Steinebach C, Ng YL. Sosič I, Lee CS, Chen S, Lindner S, Vu LP, Bricelj A, Haschemi R, Monschke M, Steinwarz E, Wagner KG, Bendas G, Luo J, Gütschow M*, Krönke J* (2020) Systematic exploration of different E3 ubiquitin ligases: An approach towards potent and selective CDK6 degraders. Chem Sci 11:3474-3486.
Häußler D, Schulz-Fincke AC, Beckmann AM, Keils A, Gilberg E, Mangold M, Bajorath J, Stirnberg M, Steinmetzer T, Gütschow M (2017) A fluorescent-labeled phosphono bisbenzguanidine as activity-based probe for matriptase. Chem. Eur. J. 23:5205-5209.
Löser R, Frizler M, Schilling K, Gütschow M (2008) Azadipeptide nitriles - highly potent and proteolytically stable inhibitors of papain-like cysteine proteases. Angew Chem Int Ed 47:4331-4334.